Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review
Objective. Psoriatic arthritis (PsA) can be treated with biological drugs targeting IL-17A, such as secukinumab, with good responses and long-term positive outcomes in clinical studies. Methods. An observational study was conducted on adult subjects with PsA and comorbidities, treated with secuki...
Saved in:
Main Authors: | Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2025-01-01
|
Series: | Reumatismo |
Subjects: | |
Online Access: | https://www.reumatismo.org/reuma/article/view/1694 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical profiling of psoriatic arthritis: an observational cross-sectional study from Karnataka Psoriatic Arthritis Cohort
by: Chanakya Kodishala, et al.
Published: (2022-01-01) -
Apremilast generic for the treatment of active psoriatic arthritis: A single-center real-life experience from India
by: Sanjiv Amin, et al.
Published: (2020-01-01) -
Secukinumab Treatment in Patients With Hidradenitis Suppurativa in Real-World Clinical Settings: A Multicenter Study
by: Ece Erbağcı, et al.
Published: (2025-01-01) -
Psoriatic arthritis: An up to date overview
by: Simon Hackett, et al.
Published: (2020-01-01) -
Wnt signaling as a translational target in rheumatoid and psoriatic arthritis
by: Gloria Riitano, et al.
Published: (2025-02-01)